Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lung cancer hope: new combo aims to stop tumor growth

NCT ID NCT07153445

Recruiting now Disease control Sponsor: Fundación GECP Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a drug called atezolizumab (Tecentriq) plus standard chemotherapy in 97 people with stage III non-small cell lung cancer. After initial treatment, some may have surgery, while others continue on atezolizumab. The goal is to see if this approach helps keep the cancer from growing or coming back.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Atezolizumab (Tecentriq) plus paclitaxel and carboplatin chemotherapy
What this could lead to
If successful, this could offer a new treatment option that delays cancer progression and improves survival for people with stage III non-small cell lung cancer.
What could go wrong
This is a phase II trial with only 97 participants, so results are preliminary. The combination may cause serious side effects, and not all patients will benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CANCER STAGE IIIA LUNG CANCER STAGE IIIB LUNG CANCER

Contacts and locations

Locations

  • Complejo Hospitalario de Navarra

    RECRUITING

    Pamplona, Pamplona, 31008, Spain

  • Hospital De Basurto

    RECRUITING

    Bilbao, Bilbao, 48013, Spain

  • Hospital General Universitario Dr. Balmis de Alicante

    RECRUITING

    Alicante, Alicante, 03010, Spain

  • Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Valencia, 46014, Spain

  • Hospital Parc Taulí

    RECRUITING

    Barcelona, Barcelona, 08208, Spain

  • Hospital Univ. De Jerez De La Frontera

    RECRUITING

    Jerez de la Frontera, Cadiz, 11407, Spain

  • Hospital Universitari Sant Joan de Reus

    RECRUITING

    Reus, Tarragona, 43204, Spain

  • Hospital Universitari Son Llatzer

    RECRUITING

    Palma de Mallorca, Palma de Mallorca, 07198, Spain

  • Hospital Universitari Vall d' Hebron

    RECRUITING

    Barcelona, Barcelona, 08035, Spain

  • Hospital Universitari de Gran Canària Doctor Negrín

    RECRUITING

    Las Palmas de Gran Canaria, Las Palmas, 35010, Spain

  • Hospital Universitario Clinico San Cecilio

    RECRUITING

    Granada, Granada, 18007, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    NOT_YET_RECRUITING

    Madrid, Madrid, 28040, Spain

  • Hospital Universitario Lucus Augusti

    RECRUITING

    Lugo, Lugo, 27003, Spain

  • Hospital Universitario Nuestra Señora La Candelaria

    RECRUITING

    Santa Cruz de Tenerife, Santa Cruz de Tenerife, 38009, Spain

  • Hospital Universitario Puerta de Hierro

    RECRUITING

    Majadahonda, Madrid, 28222, Spain

  • Hospital Universitario Salamanca

    RECRUITING

    Salamanca, Salamanca, 37007, Spain

  • Hospital Universitario Virgen Del Rocio

    RECRUITING

    Seville, Sevilla, 41013, Spain

  • Hospital de la Santa Creu i Sant Pau

    RECRUITING

    Barcelona, Barcelona, 08041, Spain

  • Hospitalario Universitario A Coruña

    RECRUITING

    A Coruña, La Coruña, 15006, Spain

  • ICO Badalona, Hospital Germans Trias i Pujol

    RECRUITING

    Badalona, Barcelona, 08916, Spain

  • ICO Girona, Hospital Josep Trueta

    RECRUITING

    Girona, Girona, 17007, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.